Are you due to have a laparoscopy for symptoms suggestive of endometriosis?

Many women with endometriosis are treated surgically, but symptoms can recur in just under half of them. Clinicians are uncertain about how best to prevent this.

endometriosis-PRE-EMTThirty two hospitals throughout the UK have joined a large national clinical trial to find out if long acting progestogen treatment (either Mirena Coil® or Depo-Provera®) is more effective compared to the oral contraceptive pill in preventing the recurrence of symptoms and improving quality of life.

The target population is women of reproductive age with laparoscopically diagnosed endometriosis, who have undergone conservative surgery for alleviation of pelvic pain, and who have no contraindications to any of the proposed hormonal treatments. The PRE-EMPT trial will be discussed with women when they are scheduled for laparoscopic surgery

The treatments offered in PRE-EMPT are:

You may be eligible to take part in the PRE-EMPT trial if you

  • are aged between 16-45 years;
  • have no immediate plans to conceive;
  • are scheduled to have laparoscopic conservative surgery, or a diagnostic laparoscopy with concurrent surgery if endometriosis is found, for pelvic pain associated with endometriosis;
  • are willing to be randomised to either:
    • one long acting progestogen (you can chose between Mirena® or Depo-provera®)OR
    • the combined oral contraceptive pill.

What the trial involves

We will collect information on your pain, physical, and emotional wellbeing at the beginning of the study. A similar questionnaire will then be sent to you at home at six months, and then at one, two, and three years after treatment. The questions are designed to find out if there are any improvements or changes in your symptoms following treatment.

Which hospitals are taking part

Aberdeen Royal InfirmaryQMC – Nottingham Treatment Centre
Addenbrooke’s (Cambridge)Royal Albert Edward Infirmary
Arrowe Park HospitalRoyal Berkshire Hospital
Basingstoke & North HampshireRoyal Infirmary of Edinburgh
Birmingham Women’s HospitalRoyal Preston Hospital
Chelsea and Westminster HospitalSouthend University Hospital
Chesterfield Royal HospitalSt Mary’s, Manchester
Cumberland Infirmary & W. Cumberland HospitalSt Peter’s Hospital
Furness General HospitalSt Richard’s Hospital, Chichester
James Cook University HospitalStoke Mandeville Hospital
John Radcliffe HospitalThe Royal Victoria Infirmary (Newcastle)
Kings Mill HospitalUniversity College London Hospital
Liverpool Women’s HospitalUniversity Hospital Crosshouse
Milton Keynes HospitalUniversity Hospital of North Durham
Peterborough City HospitalUniversity Hospital of North Tees
Princess of Wales (Wales)Yeovil District Hospital

How to participate in the trial

If you are interested in participating in this trial, please contact:

Laura Gennard
Senior Trial Coordinator
t: +44 (0)121 415 9109
f: +44 (0)121 415 9136
e: d.a.m.farrell@bham.ac.uk
Birmingham Clinical Trials Unit (BCTU)
Institute of Applied Health Research
Public Health Building
University of Birmingham
Edgbaston
Birmingham
B15 2TT

Share

Recommend, read later, or share this article

Stay up to date

Register for endometriosis news:

Connect

Twitter Follow us on Twitter

Get involved

Help us improve treatments for endometriosis and prevent this disease in the next generation of women. Support the work of the World Endometriosis Research Foundation.

Donate to research Shop for WERF Volunteer